Works Cited
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.
2. Mandawat A, Curtis JP, Mandawat, A, et al. Safety of pacemaker implantation in nonagenarians: an analysis of the Healthcare Cost and Utilization Project, Nationwide Inpatient Sample. Circulation. 2013;127(14):1453-1465.
3. Boyle J, Rost MK. Present status of cardiac pacing: a nursing perspective. Crit Care Nurs Q. 2000;23(1):1-19.
5. Kurtz SM, Ochoa JA, Lau E, et al. Implantation trends and patient profiles for pacemakers and implantable cardioverter defibrillators in the United States: 1993–2006. Pacing Clin Electrophysiol. 2010;33(6):705-711.
6. U.S. Food and Drug Administration. July 2014 PMA Approvals. Available at https://wayback.archive-it.org/7993/20170112093613/http://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/DeviceApprovalsandClearances/PMAApprovals/ucm414958.htm. Last accessed August 1, 2023.
7. Abraham WT, Hayes DL. Cardiac resynchronization therapy for heart failure. Circulation. 2003;108(21):2596-2603.
8. Gura MT, Foreman L. Cardiac resynchronization therapy for heart failure management. AACN Clin Issues. 2004;15(3):326-339.
9. Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incorporated into the ACCF/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2009;53(15):e1-e390.
10. Woods SL, Froelicher ES, Motzer SA, Bridges EJ. Cardiac Nursing. 7th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2021.
11. National Heart, Lung, and Blood Institute. How the Heart Works. Available at https://www.nhlbi.nih.gov/health/heart. Last accessed August 1, 2023.
12. National Heart, Lung, and Blood Institute. Atrial Fibrillation. Available at https://www.nhlbi.nih.gov/health/atrial-fibrillation. Last accessed August 1, 2023.
15. Beyerbach DM. Pacemakers and Implantable Cardioverter-Defibrillators. Available at https://emedicine.medscape.com/article/162245-overview. Last accessed August 23, 2023.
16. Mallela VS, Ilankumaran V, Rao NS. Trends in cardiac pacemaker batteries. Indian Pacing Electrophysiol J. 2004;4(4):201-212.
17. Medtronic. Living with a Heart Device: Overview. Available at https://www.medtronic.com/us-en/patients/treatments-therapies/living-with-heart-device.html. Last accessed August 1, 2023.
18. Heart Rhythm Society. Atrial Fibrillation (AFib). Available at https://www.upbeat.org/heart-rhythm-disorders/atrial-fibrillation-afib. Last accessed August 1, 2023.
19. Ellenbogen KA, Kaszala K (eds). Cardiac Pacing and ICDs. 7th ed. Hoboken, NJ: John Wiley & Sons; 2020.
20. Hayes DL, Asirvatham SJ, Friedman PA (eds). Cardiac Pacing, Defibrillation and Resynchronization: A Clinical Approach. 3rd ed. Hoboken, NJ: Wiley-Blackwell; 2013.
21. Moses HW, Mullin JC. A Practical Guide to Cardiac Pacing. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007.
22. Epstein AE, DiMarco JP, Ellenbogen KA, et al. 2012 ACCF/AHA/HRS focused update incorporated into the ACCF/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;61(3):e6-e75.
23. Sarko JA, Tiffany BR. Cardiac pacemakers: evaluation and management of malfunctions. Am J Emerg Med. 2000;18(4):435-440.
24. Bernstein AD, Daubert JC, Fletcher RD, et al. The revised NASPE/BPEG generic code for antibradycardia, adaptive-rate, and multisite pacing. Pacing Clin Electrophysiol. 2002;25(2):260-264.
26. Ouali S, Neffeti E, Ghoul K, et al. DDD versus VVIR pacing in patients, ages 70 and over, with complete heart block. Pacing Clin Electrophysiol. 2010;33(5):583-589.
27. Dharmendrakumar AP, Lavie CJ, Milani RV, Shah S, Gilliland Y. Clinical implications of left atrial enlargement: a review. Ochsner J. 2009;9(4):191-196.
28. Kusumoto FM, Schoenfeld MH, Edgerton JR, et al. 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society. Heart Rhythm. 2019;16(9):e129-e226.
29. Kusumoto FM, Calkins H, Boehmer J, et al. HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. Circulation. 2014;130:94-125.
30. Heart Rhythm Society. Sick Sinus Syndrome (SSS). Available at https://www.upbeat.org/heart-rhythm-disorders/sick-sinus-syndrome. Last accessed August 1, 2023.
32. Livingston MW. Sinus Bradycardia. Available at https://emedicine.medscape.com/article/760220-overview. Last accessed August 1, 2023.
33. MedlinePlus. Sick Sinus Syndrome. Available at https://medlineplus.gov/ency/article/000161.htm. Last accessed August 1, 2023.
34. Agrawal A. Third-Degree Atrioventricular Block (Complete Heart Block). Available at https://emedicine.medscape.com/article/162007-overview. Last accessed August 1, 2023.
35. Paul S. Understanding advanced concepts in atrioventricular block. Crit Care Nurse. 2001;21(1):56-66.
36. Sovari AA, Gaeta TJ Kocheril AG, Levine MD. Second-Degree Atrioventricular Block. Available at https://emedicine.medscape.com/article/161919-overview. Last accessed August 1, 2023.
37. Rosenthal L. Atrial Fibrillation. Available at https://emedicine.medscape.com/article/151066-overview. Last accessed August 1, 2023.
38. Wijetunga MN. Carotid Sinus Hypersensitivity. Available at https://emedicine.medscape.com/article/153312-overview. Last accessed August 1, 2023.
39. Wieling W, Krediet CT, Solari D, et al. At the heart of the arterial baroreflex: a physiological basis for a new classification of carotid sinus hypersensitivity. J Intern Med. 2013;273(4):345-358.
40. Vallerand AH, Sanoski CA. Davis's Drug Guide for Nurses. 18th ed. Philadelphia, PA: FA Davis Company; 2022.
41. Karliner LS, Jacobs EA, Chen AH, Mutha S. Do professional interpreters improve clinical care for patients with limited English proficiency? A systematic review of the literature. Health Serv Res. 2007;42(2):727-754.
42. Ngo-Metzger Q, Massagli MP, Clarridge BR, et al. Linguistic and cultural barriers to care: perspectives of Chinese and Vietnamese immigrants. J Gen Intern Med. 2003;18(1):44-52.
43. Merck Manual. Continuous Ambulatory Electrocardiography. Available at https://www.merckmanuals.com/home/heart-and-blood-vessel-disorders/diagnosis-of-heart-and-blood-vessel-disorders/continuous-ambulatory-electrocardiography. Last accessed August 1, 2023.
44. Diagnostic and Interventional Cardiology. An Introduction to Remote Monitoring Systems for Implantable EP Devices. Available at https://www.dicardiology.com/article/introduction-remote-monitoring-systems-implantable-ep-devices. Last accessed August 1, 2023.
45. National Heart, Lung, and Blood Institute. Heart Tests. Available at https://www.nhlbi.nih.gov/health/heart-tests. Last accessed August 1, 2023.
46. Crawford MH, Bernstein SJ, Deedwania PC, et al. ACC/AHA guidelines for ambulatory electrocardiography: executive summary and recommendations: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. Circulation. 1999;100(8):886-893.
47. MCOT Patch. Available at https://www.myheartmonitor.com/wp-content/uploads/sites/2/2020/02/MCOT-Patch.pdf. Last accessed August 1, 2023.
48. Medtronic. Remote Monitoring for Implanted Heart Devices. Available at https://www.medtronic.com/us-en/patients/treatments-therapies/remote-monitoring.html. Last accessed August 1, 2023.
49. Cardiac Monitoring.com. Mobile Cardiac Telemetry. Available at http://cardiacmonitoring.com/mobile-cardiac-telemetry. Last accessed August 1, 2023.
50. Kusumoto FM, Schoenfeld MH, Barrett C, et al. 2018 ACC/AHA/HRS guideline on the evaluation and management of patients with bradycardia and cardiac conduction delay. J Am Coll Cardiol. 2019;74(7):e51-e156.
51. National Heart, Lung, and Blood Institute. What are Pacemakers? Available at https://www.nhlbi.nih.gov/health/pacemakers. Last accessed August 1, 2023.
52. Ghanbari H, Phard WS, Al-Ameri H, et al. Meta-analysis of safety and efficacy of uninterrupted warfarin compared to heparin-based bridging therapy during implantation of cardiac rhythm devices. Am J Cardiol. 2012;110(10):1879-1913.
53. Boston Scientific. Pacemaker Device Support: Medical and Dental Procedures. Available at https://www.bostonscientific.com/en-US/patients-caregivers/device-support/pacemaker/medical-dental.html. Last accessed August 1, 2023.
54. Abbott. Electromagnetic Interference. Electromagnetic Interference: Guide to Electromagnetic Compatibility and Your Cardiac Device. Available at https://www.cardiovascular.abbott/us/en/patients/cardiovascular-device-patient-services/emi.html. Last accessed August 1, 2023.
55. Medtronic. Medtronic First to Receive FDA Approval for Pacing the Heart's Natural Conduction System. Available at https://news.medtronic.com/2022-10-17-Medtronic-First-to-Receive-FDA-Approval-for-Pacing-the-Hearts-Natural-Conduction-System. Last accessed August 1, 2023.
56. Lewis AJM, Foley P, Whinnett Z, et al. His bundle pacing: a new strategy for physiological ventricular activation. JAHA. 2019;8(6):e010972.
57. Abbott. Abbott Receives FDA Approval for World's First Dual Chamber Leadless Pacemaker. Available at https://abbott.mediaroom.com/2023-07-05-Abbott-Receives-FDA-Approval-for-Worlds-First-Dual-Chamber-Leadless-Pacemaker. Last accessed August 1, 2023.
58. Manley D. Logan Woman Becomes First Utah Patient to Get Tiny New Pacemaker. Available at https://archive.sltrib.com/article.php?id=58276080&itype=CMSID. Last accessed August 1, 2023.
59. Reardon S. Gene Therapy Creates Biological Pacemaker. Available at https://www.nature.com/news/gene-therapy-creates-biological-pacemaker-1.15569. Last accessed August 1, 2023.
60. Wilkoff BL, Auricchio A, Brugada J, et al. HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency, and ethical considerations. Heart Rhythm. 2008;5(6):907-925.
61. Zeitler EP, Piccini JP. Remote monitoring of cardiac implantable electronic devices (CIED). Trends Cardiovas Med. 2016;26(6): 568-577.
62. Centers for Medicare and Medicaid Services. Medicare Claims Processing Manual. Chapter 35—Independent Diagnostic Testing Facility (IDTF). Available at https://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/downloads/clm104c35.pdf. Last accessed August 1, 2023.
63. Ricci RP, Morichelli L, D'Onofrio A, et al. Effectiveness of remote monitoring of CIEDs in detection and treatment of clinical and device-related cardiovascular events in daily practice: the HomeGuide Registry. Europace. 2013;15(7):970-977.
64. Ghosh P. Pacemaker Malfunction. Available at https://emedicine.medscape.com/article/156583-overview. Last accessed August 1, 2023.
65. Beyerbach DM, Cadman C. Pacemaker Syndrome. Available at https://emedicine.medscape.com/article/159706-overview. Last accessed August 1, 2023.
66. U.S. Food and Drug Administration. FDA Approves First Leadless Pacemaker to Treat Heart Rhythm Disorders. Available at https://www.fda.gov/news-events/press-announcements/fda-approves-first-leadless-pacemaker-treat-heart-rhythm-disorders. Last accessed August 1, 2023.
67. The Joint Commission. Specifications Manual for Joint Commission National Quality Measures (v2018A): New York Heart Association (NYHA) Classification. Available at https://manual.jointcommission.org/releases/TJC2018A/DataElem0439.html. Last accessed August 1, 2023.
68. Centers for Disease Control and Prevention. Heart Failure. Available at https://www.cdc.gov/heartdisease/heart_failure.htm. Last accessed August 1, 2023.
70. Trupp RJ. Cardiac resynchronization therapy: optimizing the device, optimizing the patient. J Cardiovasc Nurs. 2004;19(4):223-233.
71. Flanagan J, Horwood L, Bolin C, Sample R. Heart failure patients with ventricular dysynchrony: management with a cardiac resynchronization therapy device. Prog Cardiovasc Nurs. 2003;18(4):184-189.
72. Tang WH Wilson, Francis GS. Cardiac resynchronization therapy in New York Heart Association Class IV heart failure: it is all about selection. Circulation. 2007;115:161-162.
73. Albouaini K, Egred M, Rao A, Alahmar A, Wright DJ. Cardiac resynchronization therapy: evidence-based benefits and patient selection. Eur J Intern Med.2008;19(3):165-172.
74. Agrawal, A, Guzman DB. Cardiac Resynchronization Therapy. Available at https://emedicine.medscape.com/article/1839506-overview. Last accessed August 1, 2023.
75. Narayan SM. Implantable defibrillators with and without resynchronization for patients with left ventricular dysfunction. Tex Heart Inst J. 2005;32(3):358-361.
76. Yarnoz MJ, Curtis AB. Sex-based differences in cardiac resynchronization therapy and implantable cardioverter defibrillator therapies: effectiveness and use. Cardiol Rev. 2006;14(6):292-298.
77. Linde C, Ellenbogen K, McAlister FA. Cardiac resynchronization therapy (CRT): clinical trials, guidelines, and target populations. Heart Rhythm. 2012;9(8):S3-S13.
78. Schuster P, Faerestrand S. Techniques for identification of left ventricular asynchrony for cardiac resynchronization therapy in heart failure. Indian Pacing Electrophysiol J. 2005;5(3):175-185.
79. Yu CM, Chan YS, Zhang Q, et al. Benefits of cardiac resynchronization therapy for heart failure patients with narrow QRS complexes and coexisting systolic asynchrony by echocardiography. J Am Coll Cardiol. 2006;48(11):2251-2257.
80. Quigley RL. A hybrid approach to cardiac resynchronization therapy. Ann Thorac Cardiovasc Surg. 2011;17(3):273-276.
81. Cleveland Clinic. Biventricular Pacemaker. Available at https://my.clevelandclinic.org/health/treatments/16784-biventricular-pacemaker. Last accessed August 1, 2023.
82. Kydd AC, Khan FZ, Watson WD, Pugh PJ, Virdee MS, Dutka DP. Prognostic benefit of optimum left ventricular lead position in cardiac resynchronization therapy: follow-up of the TARGET study cohort. JACC Heart Fail. 2014;2(3):205-212.
83. McAtee ME, Gawlinski A. Biventricular pacing: new treatment for patients with heart failure bears important nursing implications. Am J Nurs. 2002;102(5):4-7.
84. Saba S, Marek J, Schwartzman D, et al. Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy: results of the Speckle Tracking Assisted Resynchronization Therapy for Electrode Region trial. Circ Heart Fail. 2013;6(3):427-434.
85. Khan FZ, Virdee MS, Palmer CR, et al. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized, controlled trial. J Am Coll Cardiol. 2012;59(17):1509-1518.
86. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology /American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022;145(18):e895-e1032.
87. Bleeker GB, Schalij MJ, Holman ER, Steendijk P, van der Wall EE, Bax JJ. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy. Am J Cardiol. 2006;98(2):230-235.
88. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350(21):2140-2150.
89. Young JB, Abraham WT, Smith AL, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD Trial. JAMA. 2003;289(20):2685-2694.
91. Tracy CM, Epstein AE, Darbar D, et al. 2012 ACCF/AHA/HRS focused update of the 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2012;126:1784-1800.
92. Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC) with the special contribution of the European Heart Rhythm Association (EHRA). Eur Heart J. 2021;42:3427-3520 .
- Back to Course Home
- Participation Instructions
- Review the course material online or in print.
- Complete the course evaluation.
- Review your Transcript to view and print your Certificate of Completion. Your date of completion will be the date (Pacific Time) the course was electronically submitted for credit, with no exceptions. Partial credit is not available.